PeaceHealth Sacred Heart Medical Center at RiverBend is a 388-bed regional medical center. The hospital is located in Springfield, in the U.S. state of Oregon. Established in 2008, it is one of two Sacred Heart facilities in the Eugene-Springfield area owned by PeaceHealth.

There are 392 beds in Sacred Heart Medical Center at RiverBend.

During the past decade, Sacred Heart Medical Center at RiverBend conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sacred Heart Medical Center at RiverBend" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Asahi Intecc USA Inc" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacred Heart Medical Center at RiverBend" #1 collaborator was "Abiomed Inc." with 1 trials as a collaborator, "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator, "Medical University of South Carolina" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sacred Heart Medical Center at RiverBend" are "Coronary Artery Disease" (2 trials), "Stroke" (2 trials), "Acute Myocardial Infarction" (1 trials), "Arrhythmia, Ventricular" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Sacred Heart Medical Center at RiverBend" in a lesser frequency.

Most popular intervention types in "Sacred Heart Medical Center at RiverBend" are "Device" (9 trials), "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "Absorb BVS" (1 trials), "Albumin" (1 trials), "Control" (1 trials) and "Crossing of Coronary Artery CTO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sacred Heart Medical Center at RiverBend" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Sacred Heart Medical Center at RiverBend". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Sacred Heart Medical Center at RiverBend, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sacred Heart Medical Center at RiverBend, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".